Effects of 5 versus 3 antiretrovirals on HIV reservoir size and immunity in sigmoid colon and blood in Thai patients with acute HIV infections

Trial Profile

Effects of 5 versus 3 antiretrovirals on HIV reservoir size and immunity in sigmoid colon and blood in Thai patients with acute HIV infections

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2013

At a glance

  • Drugs Maraviroc (Primary) ; Raltegravir (Primary) ; Efavirenz; Emtricitabine; Tenofovir disoproxil fumarate
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms SEARCH 010
  • Most Recent Events

    • 06 Mar 2013 Neuropsychological performance results presented at the 20th Conference on Retroviruses and Opportunistic Infections.
    • 19 Mar 2012 New trial record
    • 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top